BamSEC and AlphaSense Join Forces
Learn More

Stoke Therapeutics Inc. – Articles of Incorporation

NASDAQ: STOK    
Share price (3/18/26): $31.02    
Market cap (3/18/26): $1.835 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 10-K 9 pages Stoke Therapeutics, Inc. Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 32 pages Stoke Therapeutics, Inc. (A Delaware Corporation) Amended and Restated Bylaws as Amended and Restated on February 2, 2023 Stoke Therapeutics, Inc. (A Delaware Corporation) Amended and Restated Bylaws
12/34/56
EX-3.2
from S-3 28 pages Stoke Therapeutics, Inc. (A Delaware Corporation) Restated Bylaws as Adopted May 10, 2019 and Amended on April 14, 2020 Stoke Therapeutics, Inc. (A Delaware Corporation) Restated Bylaws
12/34/56
EX-3.1
from 8-K 1 page Amendment to Restated Bylaws
12/34/56
EX-3.2
from 10-Q 27 pages Stoke Therapeutics, Inc. (A Delaware Corporation) Restated Bylaws as Adopted May 10, 2019 and as Effective June 21, 2019 Stoke Therapeutics, Inc. (A Delaware Corporation) Restated Bylaws
12/34/56
EX-3.1
from 10-Q 7 pages Stoke Therapeutics, Inc. Restated Certificate of Incorporation
12/34/56
EX-3.1
from S-1/A 22 pages Amended and Restated Certificate of Incorporation Amended and Restated Certificate of Incorporation of Stoke Therapeutics, Inc
12/34/56
EX-3.4
from S-1 30 pages Stoke Therapeutics, Inc. (A Delaware Corporation) Restated Bylaws as Adopted May 10, 2019 and as Effective , 2019 Stoke Therapeutics, Inc. (A Delaware Corporation) Restated Bylaws
12/34/56
EX-3.3
from S-1 17 pages Stoke Therapeutics, Inc. (Fka Asothera Pharmaceuticals, Inc.) a Delaware Corporation Bylaws as Adopted June 18, 2014 Stoke Therapeutics, Inc. (Fka Asothera Pharmaceuticals, Inc.) a Delaware Corporation Bylaws as Adopted June 18, 2014
12/34/56
EX-3.2
from S-1 7 pages Stoke Therapeutics, Inc. Restated Certificate of Incorporation
12/34/56
EX-3.1
from S-1 20 pages Amended and Restated Certificate of Incorporation Amended and Restated Certificate of Incorporation of Stoke Therapeutics, Inc
12/34/56
EX-3.3
from DRS 17 pages Stoke Therapeutics, Inc. (Fka Asothera Pharmaceuticals, Inc.) a Delaware Corporation Bylaws as Adopted June 18, 2014
12/34/56
EX-3.1
from DRS 20 pages Amended and Restated Certificate of Incorporation Amended and Restated Certificate of Incorporation of Stoke Therapeutics, Inc
12/34/56